Literature DB >> 17532239

Orbital melanotic neuroectodermal tumor of infancy successfully treated with chemotherapy and subtotal excision.

Robert W Hered1, Walter Smithwick, Eric Sandler, Jeffrey D Goldstein.   

Abstract

Melanotic neuroectodermal tumor of infancy is a rare condition that typically presents within the first 6 months of life. It rarely metastasizes but is locally aggressive. Melanotic neuroectodermal tumor of infancy has been reported under several other names including retinal anlage tumor and melanotic progonoma. Most commonly, melanotic neuroectodermal tumor of infancy originates in the maxilla. Tumors in previously reported orbital cases have arisen from adjacent structures or from orbital bone. Recommended treatment of melanotic neuroectodermal tumor of infancy has consisted of complete excision with wide tissue margins, although success has been reported after incomplete resection. For those patients in whom surgical resection is not possible, various chemotherapy approaches have been reported with mixed results ranging from failure to sustained tumor regression. We report a case of orbital melanotic neuroectodermal tumor of infancy adherent to sclera and successfully treated with chemotherapy and subtotal excision.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17532239     DOI: 10.1016/j.jaapos.2007.03.010

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  2 in total

1.  Mandibular melanotic neuroectodermal tumor of infancy: a role for neoadjuvant chemotherapy.

Authors:  Christopher Maroun; Ibrahim Khalifeh; Elie Alam; Pierre Abi Akl; Raya Saab; Roger V Moukarbel
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-23       Impact factor: 2.503

2.  Melanotic progonoma of the skull in infancy.

Authors:  Mehmet Kantar; Murat Sezak; Tuncer Turhan; Omer Kitis; Saffet Mutluer; Bengu K Demirag; Serap Aksoylar; Taner Akalin; Yusuf Ersahin; Nazan Cetingul
Journal:  Childs Nerv Syst       Date:  2008-07-01       Impact factor: 1.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.